S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Fluidigm and Olink Bioscience Bring a New Level of Protein Biomarker Discovery to the Life Science Research Market (2013/7/31)|
|Fluidigm C1 Single-Cell Auto Prep System Wins Prestigious IBO Design Award (2013/9/9)|
|Fluidigm Enables the Study of miRNA Master Regulators Down to the Single Cell Level ()|
|Fluidigm Announces Preliminary Fourth Quarter 2013 Revenue and Issues 2014 Revenue Guidance ()|
|Fluidigm Completes Acquisition of DVS Sciences (2014/2/13)|
|Fluidigm Reports Strong Q2 2013 Revenue Growth of 35% ()|
|Nature Selects “Single-Cell Sequencing” as the 2013 Method of the Year (2013/12/31)|
|Fluidigm to Present at the 32nd Annual J.P. Morgan Healthcare Conference ()|
|Fluidigm to Present at the Cowen and Company 34th Annual Health Care Conference (2014/2/26)|
|Fluidigm and DVS Sciences Announce Agreement for Fluidigm to Acquire DVS Sciences – Creating a Single-Cell Technology Powerhouse (2014/1/29)|
Click above to view more mutual fund data and stats for fldm - Fluidigm Corp.